In an elegant study, Valiente and colleagues demonstrated that brain metastatic cells from lung and breast cancers expressed high levels of anti-plasminogen activator serpins, including neuroserpin, which, by preventing the generation of plasmin, decreased the cleavage of FasL and L1CAM, thereby favouring brain metastasis in these types of cancer [98]. This evidence concerns the gene SERPINI1 and cancer.